RHÖN-KLINIKUM Aktiengesellschaft (LON: 0NQH)
London
· Delayed Price · Currency is GBP · Price in EUR
14.70
+0.05 (0.34%)
At close: Jan 22, 2025
RHÖN-KLINIKUM Aktiengesellschaft Revenue
RHÖN-KLINIKUM Aktiengesellschaft had revenue of 462.82M EUR in the quarter ending September 30, 2024, with 7.66% growth. This brings the company's revenue in the last twelve months to 1.84B, up 7.09% year-over-year. In the year 2023, RHÖN-KLINIKUM Aktiengesellschaft had annual revenue of 1.73B with 4.43% growth.
Revenue (ttm)
1.84B EUR
Revenue Growth
+7.09%
P/S Ratio
n/a
Revenue / Employee
100.59K EUR
Employees
18,246
Market Cap
832.16M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.73B | 73.57M | 4.43% |
Dec 31, 2022 | 1.66B | 69.95M | 4.40% |
Dec 31, 2021 | 1.59B | 45.15M | 2.92% |
Dec 31, 2020 | 1.55B | 65.12M | 4.40% |
Dec 31, 2019 | 1.48B | 90.46M | 6.51% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |